Logo

CatRio.com.br

Programa de Treinamento em
Hemodinâmica e Cardiologia Intervencionista


Módulo III A
Intervenções Coronárias: materiais, estratégias e técnicas

Palestrante

Farmacologia nas intervenções coronárias

Dr. Leonardo José Duarte
11 Junho 2015 ~ 32 min
* Atualização em 2017

Referências

― Guidelines & Diretrizes

Serrano Junior CV, Fenelon G, Soeiro AM, Nicolau JC, Piegas LS, Montenegro ST, et al.
Sociedade Brasileira de Cardiologia. Diretrizes Brasileiras de Antiagregantes Plaquetários e Anticoagulantes em Cardiologia.
Arq Bras Cardiol 2013; 101 (3Supl.3): 1-93. Disponível em: http://publicacoes.cardiol.br/consenso/2013/Diretriz_Antiagregantes_Anticoagulantes.pdf

― Livros

Croce K, Simon DI. Adjunctive pharmacology for cardiac catheterization. In Moscucci M. editor.
Grossman & Baim's: cardiac catheterization, angiography and intervention. Philadelphia: Lippincott Williams & Wilkins; 2013. 8th ed.
ISBN/ISSN: 9781451127409. Disponível em: http://www.lww.com/Product/9781451127409

Martinez E, Ribeiro E, Ribeiro H. Agentes antitrombóticos: heparina não-fracionada, enoxaparina, bivalirudina e pentassacarídeos.
In: Souza AGMR, Abzaid A, Rios MAM, et al. editores. Intervenções Cardiovasculares: SOLACI. São Paulo : Editora Atheneu; 2009. ISBN: 978-85-388-0043-9

Chew DP. Anticoagulation in percutaneous coronary intervention. In: Topol EJ, Teirstein PS. editors.
Textbook of interventional cardiology. Philadelphia : Elsevier Saunders; 2011. ISBN-13: 978-1437723588 / ISBN-10: 1437723586

Price MJ, Angiollilo DJ. Platelet inhibitor agents. In: Topol EJ, Teirstein PS. editors.
Textbook of interventional cardiology. Philadelphia : Elsevier Saunders; 2011. ISBN-13: 978-1437723588 / ISBN-10: 1437723586

Ray KK, Cannon CP. Lipid lowering in coronary artery disease. In: Topol EJ, Teirstein PS. editors.
Textbook of interventional cardiology. Philadelphia : Elsevier Saunders; 2011. ISBN-13: 978-1437723588 / ISBN-10: 1437723586

― Periódicos

Park K, Bavri AA. Aspirin: it's risks, benefits, and optimal use in preventing cardiovascular events.
Clive Clin J Med. 2013; 80(5):318-26. Disponível em: http://www.ccjm.org/content/80/5/318.full.pdf

Popma JJ, Weitz J, Bittl JA, et al. Antithrombotic therapy in patients undergoing coronary angioplasty.
Chest. 1998; 114:728S-41S .

Staico R, Vaz V, Cesar F, et al. Heparina não-fracionada e de baixo peso molecular: equivalência ou superioridade na intervenção coronária percutânea?
Rev Bras Cardiol Invas. 2004; 12(3): 138-145.

The SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in High-risk patients with non–st-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the synergy randomized trial.
JAMA. 2004; 292(1):45-54.

Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.
Circulation. 1995; 91:1676–88.

Nakamura S, Hall P, Gaglione A, et al. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation.
J Am Coll Cardiol. 1997; 29:21–27.

Barragan P, Sainsous JB, Silvestri MA, et al. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting.
Cathet Cardiovasc Diagn. 1994; 32:133–8.

Bertrand ME, Rupprecht H-J, Urban P, et al. The CLASSICS Investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting. The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS).
Circulation. 2000; 102:624-629.

Wiviott SD, Braunwald E, McCabe CH, et al. The TRITON–TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes.
N Engl J Med. 2007; 357:2001-15.

O'Donoghue M, Wiviott SD. Clopidogrel response variability and future therapies: Clopidogrel: Does one size fit all?
Circulation. 2006; 114:e600-e606.

Wiviott SD, Trenk D, Frelinger AL, et al. PRINCIPLE-TIMI 44 Investigators. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention : the prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation − Thrombolysis in Myocardial Infarction 44 Trial.
Circulation. 2007; 116:2923-32.

Wiviott SD, Trenk D, Braunwald E. Prasugrel.
Circulation. 2010; 122:394-403.

Wallentin L, Becker RC, Budaj A, et al. The PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
N Engl J Med. 2009; 361:1045-57.

mobiletilt
Em dispositivos móveis este site é melhor visualizado em telas no modo paisagem.